According to filings with the U.S. Securities and Exchange Commission, SonarMD is raising $4,344,729.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Beth Houck played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About SonarMD
SonarMD is the leading value-based care coordination program for digestive health. We partner with health plans and providers to align incentives around proactive, cost-effective care for patients with chronic gut health conditions. Our holistic approach ensures timely access to expert support, personalized care pathways and the best innovations in GI care. We know chronic gut health conditions can be complex to predict, treat and manage. That’s why SonarMD is designed to proactively identify deteriorating symptoms often before patients know theres a problem enabling care teams to intervene faster and prevent complications. The result? We keep patients healthier and lower the overall cost of care. SonarMD is proven to engage 85% of patients, reduce ER visits and hospitalizations by 50% and drive 15% cost savings per member per year.

To learn more about SonarMD, visit http://sonarmd.com/

Contact:
Beth Houck, Chief Executive Officer
312-283-0601

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.